Condition reference
PainPediatric patient pain
Explore the linked guideline and related drug references. A matching drug entry does not establish a treatment recommendation.
WSAVA guideline
Guidelines for the Recognition, Assessment and Treatment of Pain
Paediatric patients are kittens/puppies up to 12 weeks of age. Unrelieved pain in human neonates is "remembered" and alters responses to later painful stimuli; these phenomena also occur in animals — so neonates must receive analgesia. Young animals clear drugs more slowly (↑body water/Vd; ↑perfused tissue fraction; immature hepatic enzymes; ↓GFR) and CNS drugs reach higher brain levels via an immature blood–brain barrier. Opioids (titrated IV fentanyl, or buprenorphine) are the mainstay; NSAIDs need screening; LAs at reduced dosing; α2 agonists generally avoided despite successful total-injectable kitten protocols.
WSAVA Guidelines for the Recognition, Assessment and Treatment of Pain (2022/2023, JSAP doi 10.1111/jsap.13566)
Key findings
- Neonates feel and "remember" pain: human infants denied analgesia show increased sensitivity at later procedures (Taddio 1997); applies to animals. Paediatric = kitten/puppy up to 12 weeks (card; §3.10).
- Four immaturities reduce clearance: ↑body water → higher Vd; larger highly perfused tissue mass; incomplete hepatic-enzyme maturation; ↓GFR — dosing intervals may need alteration. CNS drugs reach higher neonatal brain levels (BBB/efflux immaturity) (card).
- Opioids: lower fentanyl/morphine doses needed at 0–2 wk vs 5 wk; young more sensitive to morphine sedation/respiratory depression; fentanyl suitable but short-acting (continuous IV + titration); buprenorphine alternative, minimal respiratory depression; reverse overdosage with titrated naloxone. Hydromorphone antinociception in cats shorter/lower at 6 vs 9–12 months (card).
- NSAIDs: rarely authorised <12–16 wk, but meloxicam approved ≥6 wk in some countries; 380 kittens (8–12 wk) given carprofen/meloxicam pre-neutering — no adverse effects (Porters 2015); ensure not hypovolaemic/hypotensive (card).
- Local anaesthetics whenever possible; topical EMLA (2.5% lidocaine/2.5% prilocaine) or 4% liposomal lidocaine, occlusive dressing, onset 15–20 min; reduce repeat doses/CRI rates vs adults (accumulation) (card).
- Alpha-2 agonists not recommended (neonatal cardiac output is HR-dependent; α2 bradycardia), yet α2+ketamine+opioid total-injectable protocols succeed in kittens <12 wk. Non-pharmacologic care: suckling, swaddling, dam/human contact, warmth; avoid separation from littermates/dam (card).
Drugs named in WSAVA’s own guideline text
As printed in WSAVA’s document, not this app’s own extracted data — see “Related drugs in this reference” below for that.
Fentanyl / morphine / buprenorphine (Puppy/kitten)
Carprofen or meloxicam (Kitten 8–12 wk)
EMLA (lidocaine 2.5%/prilocaine 2.5%) or 4% liposomal lidocaine (Puppy/kitten)
Injectable local anaesthetics (Puppy/kitten)
Medetomidine/dexmedetomidine + ketamine + opioid (Kitten <12 wk)
Recommendations
Treat neonatal pain — neonates feel and "remember" it
Strong (human-neonate data; GPC)
Opioids as backbone; prefer fentanyl (IV titration) or buprenorphine; reverse overdose with titrated naloxone
Expert consensus (GPC); Luks 1998
NSAIDs permissible with screening (not hypovolaemic/hypotensive)
Clinical series (Porters 2015) + GPC
Use LA techniques whenever possible; reduce repeat/CRI doses vs adults
Expert consensus (GPC)
Avoid α2 agonists as a class, accepting published α2+ketamine+opioid protocols
Expert consensus (GPC); Joyce & Yates 2011
Pair drugs with non-pharmacologic care (suckling, swaddling, warmth); clinical response guides dosing
Expert consensus (GPC)
Related drugs in this reference (0)
No indication text currently matches this condition by name. Try a broader condition or search the drug reference directly. Absence of a match does not establish that treatment is unavailable.
Built from the Pediatric Pain card and guideline §3.10 (EN part03; card matches guideline text, which adds cat topical-LA safety and neonatal-separation advice), cross-checked against summaries/02-pain-2022.md §3b. The card prints almost no numeric paediatric doses; only printed values (15–20 min onset; 27–30 G; 380-kitten series; ≥6-wk meloxicam label) are reproduced; adult dose tables apply with stated reductions.